Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11709433rdf:typepubmed:Citationlld:pubmed
pubmed-article:11709433lifeskim:mentionsumls-concept:C0043210lld:lifeskim
pubmed-article:11709433lifeskim:mentionsumls-concept:C0016536lld:lifeskim
pubmed-article:11709433lifeskim:mentionsumls-concept:C0019010lld:lifeskim
pubmed-article:11709433lifeskim:mentionsumls-concept:C0000934lld:lifeskim
pubmed-article:11709433lifeskim:mentionsumls-concept:C0002349lld:lifeskim
pubmed-article:11709433lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:11709433lifeskim:mentionsumls-concept:C0332206lld:lifeskim
pubmed-article:11709433lifeskim:mentionsumls-concept:C0599756lld:lifeskim
pubmed-article:11709433pubmed:issue6lld:pubmed
pubmed-article:11709433pubmed:dateCreated2001-11-15lld:pubmed
pubmed-article:11709433pubmed:abstractTextWe hypothesized that blockade of alpha(1)-adrenergic receptors would prevent the rise in peripheral vascular resistance that normally occurs during acclimatization. Sixteen eumenorrheic women were studied at sea level (SL) and at 4,300 m (days 3 and 10). Volunteers were randomly assigned to take the selective alpha(1)-blocker prazosin or placebo. Venous compliance, forearm vascular resistance, and blood flow were measured using plethysmography. Venous compliance fell by day 3 in all subjects (1.39 +/- 0.30 vs. 1.62 +/- 0.43 ml. Delta 30 mmHg(-1) x 100 ml tissue(-1) x min(-1) at SL, means +/- SD). Altitude interacted with prazosin treatment (P < 0.0001) such that compliance returned to SL values by day 10 in the prazosin-treated group (1.68 +/- 0.19) but not in the placebo-treated group (1.20 +/- 0.10, P < 0.05). By day 3 at 4,300 m, all women had significant falls in resistance (35.2 +/- 13.2 vs. 54.5 +/- 16.1 mmHg x ml(-1) x min(-1) at SL) and rises in blood flow (2.5 +/- 1.0 vs. 1.6 +/- 0.5 ml. 100 ml tissue(-1) x min(-1) at SL). By day 10, resistance and flow returned toward SL, but this return was less in the prazosin-treated group (resistance: 39.8 +/- 4.6 mmHg x ml(-1) x min(-1) with prazosin vs. 58.5 +/- 9.8 mmHg x ml(-1) x min(-1) with placebo; flow: 1.9 +/- 0.7 ml. 100 ml tissue(-1) x min(-1) with prazosin vs. 2.3 +/- 0.3 ml x 100 ml tissue(-1) x min(-1) with placebo, P < 0.05). Lower resistance related to higher circulating epinephrine in both groups (r = -0.50, P < 0.0001). Higher circulating norepinephrine related to lower venous compliance in the placebo-treated group (r = -0.42, P < 0.05). We conclude that alpha(1)-adrenergic stimulation modulates peripheral vascular changes during acclimatization.lld:pubmed
pubmed-article:11709433pubmed:languageenglld:pubmed
pubmed-article:11709433pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11709433pubmed:citationSubsetIMlld:pubmed
pubmed-article:11709433pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11709433pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11709433pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11709433pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11709433pubmed:statusMEDLINElld:pubmed
pubmed-article:11709433pubmed:monthDeclld:pubmed
pubmed-article:11709433pubmed:issn0363-6135lld:pubmed
pubmed-article:11709433pubmed:authorpubmed-author:YoungD ADAlld:pubmed
pubmed-article:11709433pubmed:authorpubmed-author:MooreL GLGlld:pubmed
pubmed-article:11709433pubmed:authorpubmed-author:BraunBBlld:pubmed
pubmed-article:11709433pubmed:authorpubmed-author:DouglasMMlld:pubmed
pubmed-article:11709433pubmed:authorpubmed-author:ZamudioSSlld:pubmed
pubmed-article:11709433pubmed:authorpubmed-author:MazzeoR SRSlld:pubmed
pubmed-article:11709433pubmed:authorpubmed-author:WolfelE EEElld:pubmed
pubmed-article:11709433pubmed:authorpubmed-author:MuzaS RSRlld:pubmed
pubmed-article:11709433pubmed:authorpubmed-author:RockP BPBlld:pubmed
pubmed-article:11709433pubmed:authorpubmed-author:ButterfieldG...lld:pubmed
pubmed-article:11709433pubmed:issnTypePrintlld:pubmed
pubmed-article:11709433pubmed:volume281lld:pubmed
pubmed-article:11709433pubmed:ownerNLMlld:pubmed
pubmed-article:11709433pubmed:authorsCompleteYlld:pubmed
pubmed-article:11709433pubmed:paginationH2636-44lld:pubmed
pubmed-article:11709433pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11709433pubmed:meshHeadingpubmed-meshheading:11709433...lld:pubmed
pubmed-article:11709433pubmed:meshHeadingpubmed-meshheading:11709433...lld:pubmed
pubmed-article:11709433pubmed:meshHeadingpubmed-meshheading:11709433...lld:pubmed
pubmed-article:11709433pubmed:meshHeadingpubmed-meshheading:11709433...lld:pubmed
pubmed-article:11709433pubmed:meshHeadingpubmed-meshheading:11709433...lld:pubmed
pubmed-article:11709433pubmed:meshHeadingpubmed-meshheading:11709433...lld:pubmed
pubmed-article:11709433pubmed:meshHeadingpubmed-meshheading:11709433...lld:pubmed
pubmed-article:11709433pubmed:meshHeadingpubmed-meshheading:11709433...lld:pubmed
pubmed-article:11709433pubmed:meshHeadingpubmed-meshheading:11709433...lld:pubmed
pubmed-article:11709433pubmed:meshHeadingpubmed-meshheading:11709433...lld:pubmed
pubmed-article:11709433pubmed:meshHeadingpubmed-meshheading:11709433...lld:pubmed
pubmed-article:11709433pubmed:meshHeadingpubmed-meshheading:11709433...lld:pubmed
pubmed-article:11709433pubmed:meshHeadingpubmed-meshheading:11709433...lld:pubmed
pubmed-article:11709433pubmed:meshHeadingpubmed-meshheading:11709433...lld:pubmed
pubmed-article:11709433pubmed:meshHeadingpubmed-meshheading:11709433...lld:pubmed
pubmed-article:11709433pubmed:year2001lld:pubmed
pubmed-article:11709433pubmed:articleTitleWomen at altitude: forearm hemodynamics during acclimatization to 4,300 m with alpha(1)-adrenergic blockade.lld:pubmed
pubmed-article:11709433pubmed:affiliationWomen's Health Research Center, University of Colorado Health Sciences Center, Denver, 80262, USA. Stacy.Zamudio@uchsc.edulld:pubmed
pubmed-article:11709433pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11709433pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:11709433pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:11709433pubmed:publicationTypeRandomized Controlled Triallld:pubmed